Wang et al., 1998 - Google Patents
CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120Wang et al., 1998
View HTML- Document ID
- 17348729656290702349
- Author
- Wang W
- Dudek T
- Zhao Y
- Brumblay H
- Essex M
- Lee T
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
The seven-transmembrane CCR5 was recently found to double as a coreceptor for a genetically diverse family of human and nonhuman primate lentiviruses. Paradoxically, the main region of the envelope protein believed to be involved in CCR5 utilization was mapped …
- 101700043583 CCR5 0 title abstract description 105
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120 | |
Hoffman et al. | HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors | |
Dunfee et al. | The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia | |
Chabot et al. | Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates | |
Zhang et al. | Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro | |
Tokunaga et al. | Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates | |
Lin et al. | A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding | |
Edinger et al. | CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain | |
Lu et al. | Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains | |
Edinger et al. | Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains | |
Owen et al. | Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry | |
Kolchinsky et al. | Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops | |
Gorry et al. | Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate | |
Hung et al. | Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization | |
Zhang et al. | Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1 | |
Sullivan et al. | Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies | |
Trkola et al. | Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage | |
Hofmann et al. | Species-specific, postentry barriers to primate immunodeficiency virus infection | |
Kootstra et al. | Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells | |
Kolchinsky et al. | Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication | |
Picard et al. | Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion | |
Harouse et al. | CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques | |
Goodenow et al. | HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes | |
Edinger et al. | Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains | |
Pizzato | MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1 |